Oxford Gene Technology Developed Novel Biomarker for Improved Lupus Diagnosis
Tuesday, May 14, 2013
The British company Oxford Gene Technology (OGT) announced the development of a novel biomarker panel to improve diagnosis of lupus.
The biomarker panel has been rigorously tested among samples from North American, European and Afro-Caribbean lupus patients and shown to be Our more sensitive and specific than existing laboratory tests.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms